CD4 and neoplasm: We used patient tumor slices to explore individual patient immune landscapes using multiplex immunofluorescence (IF) using a panel that detects CD4+ T cells, CD8+ T cells, regulatory T cells (Tregs), macrophages, and B cells (Fig. 3A and table S1).